# Gnosis Neurodynamics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/gnosis-neurodynamics

- Industry: Healthcare IT
- Headquarters: Beijing, China
- Total disclosed funding: $15M
- Latest round: Series A (Jun 5, 2026)
- Investors on record: 6

## About

Based in Beijing, China and founded in 2021, Lingxi Medical Technology (Beijing) Co., Ltd., trading under the name Gnosis Neurodynamics, provides brain-computer interface (BCI) data platform and AI model solutions for the digital health and neurotechnology industry. In June 2026, it raised nearly CNY 100 million in series A funding. Gnosis Neurodynamics develops products and platforms centered on brain-computer interface data and neurodynamics models, offering solutions including clinical brain data platforms, AI brain function assessment systems, and quantitative analysis and assisted diagnosis tools, while focusing on EEG-based brain function analysis, multi-modal data integration, and neurodynamics large models, enabling applications such as depression, cognitive impairment, schizophrenia, sleep disorders, epilepsy, and genetically driven pediatric developmental disorder. The company generates revenue by providing brain data platform services, AI-enabled clinical assessment systems, and related software and technology services for hospitals, clinical departments, pharmaceutical companies, and healthcare institutions. The company will use the series A funding to enhance its advantages in clinical big data and neurodynamic large models of brain-computer interfaces, as well as to promote clinical research on the registration certificate of Class III medical devices for AI brain function assessment systems for core indications such as depression and Alzheimer's disease.

## Funding rounds

- Series A, Jun 5, 2026, $15M — Delian Capital, China Xiongan Group Fund Management, Shanghai Engine Fund, Shanghai Minhang Financial Investment Development, HYTOP Smart Control Co., Ltd, Sanbo Brain Hospital

## Investors

- Delian Capital (https://capitalatlas.ai/funds/delian-capital) — Series A
- China Xiongan Group Fund Management (https://capitalatlas.ai/funds/china-xiongan-group-fund-management) — Series A
- Shanghai Engine Fund (https://capitalatlas.ai/funds/shanghai-engine-fund) — Series A
- Shanghai Minhang Financial Investment Development — Series A
- HYTOP Smart Control Co., Ltd — Series A
- Sanbo Brain Hospital — Series A